Cerebral Palsy Insurance Denied: How to Appeal for Your Child's Habilitative Services

Cerebral palsy (CP) is the most common motor disability in childhood, affecting approximately 1 in 345 children in the United States. CP results from damage to the developing brain and affects movement, muscle tone, posture, and often communication and cognition. It is not curable, but with appropriate habilitative services and medical interventions, children with CP can achieve significant functional improvement.

Insurance denials for CP care are among the most persistent and harmful claim disputes families face. Understanding the legal and clinical framework for these denials is essential to successfully appealing them.

EPSDT: The Foundation for Medicaid-Covered CP Care

For children with CP on Medicaid or CHIP, EPSDT is the most powerful legal protection available. Under 42 U.S.C. § 1396d(r), Medicaid must cover any service that is medically necessary for a child under 21 — including habilitative services that are not typically covered for adults.

Habilitative services are services that help a person acquire or maintain functional skills, as opposed to rehabilitative services that restore lost function. The distinction matters because some insurers argue that CP therapy is habilitative rather than rehabilitative and therefore not covered. The ACA requires that marketplace and small group plans cover habilitative services as an Essential Health Benefit.

For Medicaid enrollees, EPSDT eliminates the rehabilitative/habilitative distinction: if physical therapy, occupational therapy, or speech-language pathology is medically necessary for a child with CP, it must be covered regardless of how it is categorized.

Physical Therapy, Occupational Therapy, and Speech-Language Pathology

CP therapy visit limits are among the most commonly contested insurance denials for children with this condition. Plans often impose annual visit caps — 20 or 30 visits per therapy type — that are entirely inadequate for children with moderate or severe CP who require consistent, ongoing therapy to maintain and progress in function.

To challenge visit limits:

1. Document the child's current functional status and the therapy goals in the current plan of care
2. Obtain a letter from each treating therapist explaining why continued therapy above the visit limit is medically necessary
3. Cite the ACA's requirement that habilitative service limits not be more restrictive than those applied to comparable medical services under Mental Health Parity Act (MHPAEA) Explained" class="auto-link">MHPAEA
4. For Medicaid/CHIP: explicitly invoke EPSDT and argue that visit caps cannot be applied to children under 21 when therapy is medically necessary

Botox Injections for Spasticity Management

Botulinum toxin A (Botox) injections for spasticity management in children with CP are a well-established, evidence-based intervention. They reduce muscle tone, improve range of motion, and enhance the effectiveness of physical therapy. Botox for spasticity is FDA-approved for children.

Insurance denials for Botox in CP often arise from:

• Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization requirements with adult-oriented spasticity criteria
• Frequency limits (typically every 3 to 4 months) that may not match a child's clinical needs
• Denial of the facility or specialist administering the injections

To appeal a Botox spasticity denial, include a letter from the treating physiatrist or neurologist documenting the degree of spasticity (using the Modified Ashworth Scale or similar), the muscles targeted, and the expected functional outcome. Reference American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) evidence tables for Botox in CP.

Intrathecal Baclofen Pump

For children with severe spasticity affecting multiple muscle groups, an intrathecal baclofen (ITB) pump delivers baclofen directly to the spinal fluid, providing more effective spasticity reduction with fewer systemic side effects than oral baclofen. ITB therapy requires surgical implantation of a programmable pump and regular refill procedures.

Insurers sometimes deny ITB pump implantation as not medically necessary or as experimental. ITB therapy for spasticity in CP is well-established and endorsed by AACPDM. A strong appeal should include:

• Documentation of failed oral baclofen and other spasticity-reducing medications
• Functional assessment data showing the degree of spasticity and its impact on the child's care, comfort, and function
• A letter from the neurosurgeon and physiatrist supporting ITB therapy
• AACPDM care pathway evidence summaries

Hippotherapy and Equine-Assisted Therapy

Hippotherapy — the use of horseback riding as a therapeutic medium under the direction of a licensed physical, occupational, or speech-language therapist — is sometimes recommended for children with CP. Insurers almost universally classify hippotherapy as "investigational" or "not medically necessary."

This is a difficult coverage fight. Hippotherapy does have a growing evidence base for some outcomes in children with CP, but most major insurers and Medicaid programs do not cover it. If the therapy is delivered by a licensed PT or OT who uses riding as a medium but bills for PT or OT services (not "hippotherapy"), some coverage may be available. Confirm with the provider how services are being billed.

Selective Dorsal Rhizotomy

Selective dorsal rhizotomy (SDR) is a neurosurgical procedure that permanently reduces spasticity by selectively cutting sensory nerve rootlets in the spinal cord. It is performed at a small number of specialized pediatric neurosurgery centers and is highly effective for appropriately selected children with CP — primarily ambulatory children with spastic diplegia.

SDR is not experimental; it has a 40-year evidence base. However, because it is performed at a limited number of centers, it is often out-of-network. Appeal strategies should include network adequacy arguments (no in-network center performs SDR), a detailed letter from the neurosurgeon documenting the child's candidacy, and for Medicaid enrollees, invocation of EPSDT and non-emergency medical transportation rights.

Fight Back With ClaimBack

Children with cerebral palsy deserve access to all medically appropriate interventions, not just the cheapest ones. ClaimBack helps families build appeals for CP care denials backed by federal law, clinical guidelines, and medical evidence.

Start your cerebral palsy appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Common Reasons Insurance Claims Are Denied